Target intelligence / Profile preview

NSA2 pseudogene 1 (NSA2P1)

Target
NSA2P1
Molecular classification
Pseudogene, Long non-coding RNA / lncRNA
01

Overview

NSA2 pseudogene 1 (NSA2P1) is a pseudogene—a non-functional genomic DNA sequence similar to the functional NSA2 gene (which encodes a nucleolar protein involved in ribosome biogenesis and cell proliferation)[1]. NSA2P1 lacks the ability to encode a functional protein. Like other pseudogenes, it may play regulatory roles at the RNA level (e.g., as a non-coding RNA) but has no recognized molecular or clinical relevance[3][5]. There is no scientific evidence that NSA2P1 serves as a therapeutic target, biomarker, or has a documented biological or disease function. Its parental gene, NSA2, is a nucleolar factor but this functional activity does not extend to the pseudogene[1]. Therefore, NSA2P1 is not considered a molecule of direct therapeutic or diagnostic interest. NSA2P1 is not a protein-coding gene, receptor, enzyme, transporter, or therapeutic target. No structured information exists supporting its consideration as a drug target or clinical biomarker. There is no evidence that it is referred to by other names, or that it has function or relevance beyond its sequence similarity to NSA2.

02

Mechanism of action

Not applicable; no drugs known to target this pseudogene

03

Biological functions

Unknown for NSA2P1 specifically; pseudogenes may contribute to epigenetic regulation, RNA interference, or regulate parental gene expression through non-coding RNA mechanisms[3][5].
04

Disease associations

None established for NSA2P1; no evidence supporting a role as a disease biomarker or therapeutic target

Beyond the preview

Go deeper on NSA2 pseudogene 1 (NSA2P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NSA2 pseudogene 1 (NSA2P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call